A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, As Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients
Cancers（2022）
关键词
early-stage non-small cell lung cancer (NSCLC),liquid biopsy,exosome-miRNA,peptidome,fibrinopeptide A,prognostic signature,miR-130a-3p,risk score,disease recurrence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要